Why the study?
Does an antibacterial mesh envelope reduce cardiovascular implantable electronic device infection in patients undergoing device implantation?
Population
Patients undergoing cardiovascular implantable electronic device implantation
Design
Review
Authors
Loading...
Supports potential benefit but should not change practice; leaves open large RCTs for confirmation.
Does an antibacterial mesh envelope reduce cardiovascular implantable electronic device infection in patients undergoing device implantation?
The use of an antibacterial mesh envelope impregnated with rifampin and minocycline appears to significantly reduce the risk of infection following cardiovascular electronic device implantation.
Bloom et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: